Skip to main content

Table 4 Correlation between ATF5 expression and clinicopathologic charateristics of 140 bladder cancer

From: Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer

Characteristic ATF5 protein level Chi-square test
High (65) Low(75) P value
Age (> 60 versus ≤ 60 years) 36/29 42/33 0.942
Gender (M versus F) 46/19 60/15 0.238
Grade (low versus high) 42/23 61/14 0.034*
Stage (Ta-1 versus T2-4) 45/20 65/10 0.014*
Tumor Size (> 3 cm versus ≤ 3 cm) 21/44 14/61 0.079
Multiplicity (single versus multiple) 37/28 60/15 0.004**
Recurrence (Yes versus No) 24/41 14/61 0.022*
Progression (Yes versus No) 18/47 8/67 0.016*
  1. *P < 0.05, **P < 0.01